Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 1996 Sep 15;318(Pt 3):871–878. doi: 10.1042/bj3180871

Stable overexpression of the type-1 inositol 1,4,5-trisphosphate receptor in L fibroblasts: subcellular distribution and functional consequences.

J J Mackrill 1, R A Wilcox 1, A Miyawaki 1, K Mikoshiba 1, S R Nahorski 1, R A Challiss 1
PMCID: PMC1217698  PMID: 8836131

Abstract

InsP3 receptor (InsP3R)/Ca(2+)-release channels differ markedly in abundance in different tissues/cell types and InsP3R expression levels may be modulated in response to a variety of external cues. Cell lines overexpressing InsP3Rs will provide useful models for the study of the influence of receptor density and subtype on InsP3-mediated Ca2+ signalling. We have investigated the properties of InsP3Rs in mouse L fibroblast cell lines transfected with either type-1 InsP3R cDNA (L15) or vector control (Lvec). L15 cells express approximately eightfold higher levels of the type-1 InsP3R protein than Lvec cells, as assessed by radioligand binding and immunoblotting. Increased expression was stable since it did not alter over ten cell passages. Both L15 and Lvec cells express predominantly the type-1 InsP3R isoform, indicating that functional differences in the InsP3-mediated Ca2+ signalling in these cell lines are due to alteration in the levels of receptor rather than changes in the isoform expressed. Type-1 InsP3R in L15 cells is largely associated with subcellular membrane fractions bearing the sarco/endoplasmic reticulum Ca2+ ATPase pump, appropriate for rapidly exchanging Ca2+ pools. Functionally, there is an approximately fourfold increase in the sensitivity of permeabilized L15-cell Ca2+ mobilization in response to increasing concentrations of Ins(1,4,5)P3. This study indicates that L15/ Lvec cells provide a suitable model for studying the effects of InsP3R expression level on InsP3-induced Ca2+ mobilization.

Full Text

The Full Text of this article is available as a PDF (486.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berridge M. J. Inositol trisphosphate and calcium signalling. Nature. 1993 Jan 28;361(6410):315–325. doi: 10.1038/361315a0. [DOI] [PubMed] [Google Scholar]
  2. Blondel O., Bell G. I., Moody M., Miller R. J., Gibbons S. J. Creation of an inositol 1,4,5-trisphosphate-sensitive Ca2+ store in secretory granules of insulin-producing cells. J Biol Chem. 1994 Nov 4;269(44):27167–27170. [PubMed] [Google Scholar]
  3. Blondel O., Takeda J., Janssen H., Seino S., Bell G. I. Sequence and functional characterization of a third inositol trisphosphate receptor subtype, IP3R-3, expressed in pancreatic islets, kidney, gastrointestinal tract, and other tissues. J Biol Chem. 1993 May 25;268(15):11356–11363. [PubMed] [Google Scholar]
  4. Challiss R. A., Willcocks A. L., Mulloy B., Potter B. V., Nahorski S. R. Characterization of inositol 1,4,5-trisphosphate- and inositol 1,3,4,5-tetrakisphosphate-binding sites in rat cerebellum. Biochem J. 1991 Mar 15;274(Pt 3):861–867. doi: 10.1042/bj2740861. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Changeux J. P., Devillers-Thiéry A., Chemouilli P. Acetylcholine receptor: an allosteric protein. Science. 1984 Sep 21;225(4668):1335–1345. doi: 10.1126/science.6382611. [DOI] [PubMed] [Google Scholar]
  6. Chen S. R., Vaughan D. M., Airey J. A., Coronado R., MacLennan D. H. Functional expression of cDNA encoding the Ca2+ release channel (ryanodine receptor) of rabbit skeletal muscle sarcoplasmic reticulum in COS-1 cells. Biochemistry. 1993 Apr 13;32(14):3743–3753. doi: 10.1021/bi00065a029. [DOI] [PubMed] [Google Scholar]
  7. Colyer J., Mata A. M., Lee A. G., East J. M. Effects on ATPase activity of monoclonal antibodies raised against (Ca2+ + Mg2+)-ATPase from rabbit skeletal muscle sarcoplasmic reticulum and their correlation with epitope location. Biochem J. 1989 Sep 1;262(2):439–447. doi: 10.1042/bj2620439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Dawson A. P. GTP enhances inositol trisphosphate-stimulated Ca2+ release from rat liver microsomes. FEBS Lett. 1985 Jun 3;185(1):147–150. doi: 10.1016/0014-5793(85)80759-6. [DOI] [PubMed] [Google Scholar]
  9. De Smedt H., Missiaen L., Parys J. B., Bootman M. D., Mertens L., Van Den Bosch L., Casteels R. Determination of relative amounts of inositol trisphosphate receptor mRNA isoforms by ratio polymerase chain reaction. J Biol Chem. 1994 Aug 26;269(34):21691–21698. [PubMed] [Google Scholar]
  10. Ehrlich B. E., Watras J. Inositol 1,4,5-trisphosphate activates a channel from smooth muscle sarcoplasmic reticulum. Nature. 1988 Dec 8;336(6199):583–586. doi: 10.1038/336583a0. [DOI] [PubMed] [Google Scholar]
  11. Feng L., Kraus-Friedmann N. Association of the hepatic IP3 receptor with the plasma membrane: relevance to mode of action. Am J Physiol. 1993 Dec;265(6 Pt 1):C1588–C1596. doi: 10.1152/ajpcell.1993.265.6.C1588. [DOI] [PubMed] [Google Scholar]
  12. Fischer G. A., Clementi E., Raichman M., Südhof T., Ullrich A., Meldolesi J. Stable expression of truncated inositol 1,4,5-trisphosphate receptor subunits in 3T3 fibroblasts. Coordinate signaling changes and differential suppression of cell growth and transformation. J Biol Chem. 1994 Jul 29;269(30):19216–19224. [PubMed] [Google Scholar]
  13. Fujimoto T., Nakade S., Miyawaki A., Mikoshiba K., Ogawa K. Localization of inositol 1,4,5-trisphosphate receptor-like protein in plasmalemmal caveolae. J Cell Biol. 1992 Dec;119(6):1507–1513. doi: 10.1083/jcb.119.6.1507. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Furuichi T., Kohda K., Miyawaki A., Mikoshiba K. Intracellular channels. Curr Opin Neurobiol. 1994 Jun;4(3):294–303. doi: 10.1016/0959-4388(94)90089-2. [DOI] [PubMed] [Google Scholar]
  15. Furuichi T., Yoshikawa S., Miyawaki A., Wada K., Maeda N., Mikoshiba K. Primary structure and functional expression of the inositol 1,4,5-trisphosphate-binding protein P400. Nature. 1989 Nov 2;342(6245):32–38. doi: 10.1038/342032a0. [DOI] [PubMed] [Google Scholar]
  16. Guillemare E., Honoré E., Pradier L., Lesage F., Schweitz H., Attali B., Barhanin J., Lazdunski M. Effects of the level of mRNA expression on biophysical properties, sensitivity to neurotoxins, and regulation of the brain delayed-rectifier K+ channels Kv1.2. Biochemistry. 1992 Dec 15;31(49):12463–12468. doi: 10.1021/bi00164a024. [DOI] [PubMed] [Google Scholar]
  17. Hirota J., Michikawa T., Miyawaki A., Takahashi M., Tanzawa K., Okura I., Furuichi T., Mikoshiba K. Adenophostin-medicated quantal Ca2+ release in the purified and reconstituted inositol 1,4,5-trisphosphate receptor type 1. FEBS Lett. 1995 Jul 17;368(2):248–252. doi: 10.1016/0014-5793(95)00659-w. [DOI] [PubMed] [Google Scholar]
  18. Khan A. A., Steiner J. P., Klein M. G., Schneider M. F., Snyder S. H. IP3 receptor: localization to plasma membrane of T cells and cocapping with the T cell receptor. Science. 1992 Aug 7;257(5071):815–818. doi: 10.1126/science.1323146. [DOI] [PubMed] [Google Scholar]
  19. Khodakhah K., Ogden D. Functional heterogeneity of calcium release by inositol trisphosphate in single Purkinje neurones, cultured cerebellar astrocytes, and peripheral tissues. Proc Natl Acad Sci U S A. 1993 Jun 1;90(11):4976–4980. doi: 10.1073/pnas.90.11.4976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Maranto A. R. Primary structure, ligand binding, and localization of the human type 3 inositol 1,4,5-trisphosphate receptor expressed in intestinal epithelium. J Biol Chem. 1994 Jan 14;269(2):1222–1230. [PubMed] [Google Scholar]
  21. Mikoshiba K. Inositol 1,4,5-trisphosphate receptor. Trends Pharmacol Sci. 1993 Mar;14(3):86–89. doi: 10.1016/0165-6147(93)90069-v. [DOI] [PubMed] [Google Scholar]
  22. Miyawaki A., Furuichi T., Maeda N., Mikoshiba K. Expressed cerebellar-type inositol 1,4,5-trisphosphate receptor, P400, has calcium release activity in a fibroblast L cell line. Neuron. 1990 Jul;5(1):11–18. doi: 10.1016/0896-6273(90)90029-f. [DOI] [PubMed] [Google Scholar]
  23. Newton C. L., Mignery G. A., Südhof T. C. Co-expression in vertebrate tissues and cell lines of multiple inositol 1,4,5-trisphosphate (InsP3) receptors with distinct affinities for InsP3. J Biol Chem. 1994 Nov 18;269(46):28613–28619. [PubMed] [Google Scholar]
  24. Nigam S. K., Blobel G. Cyclic AMP-dependent protein kinase in canine pancreatic rough endoplasmic reticulum. J Biol Chem. 1989 Oct 5;264(28):16927–16932. [PubMed] [Google Scholar]
  25. Pietri F., Hilly M., Mauger J. P. Calcium mediates the interconversion between two states of the liver inositol 1,4,5-trisphosphate receptor. J Biol Chem. 1990 Oct 15;265(29):17478–17485. [PubMed] [Google Scholar]
  26. Renard-Rooney D. C., Hajnóczky G., Seitz M. B., Schneider T. G., Thomas A. P. Imaging of inositol 1,4,5-trisphosphate-induced Ca2+ fluxes in single permeabilized hepatocytes. Demonstration of both quantal and nonquantal patterns of Ca2+ release. J Biol Chem. 1993 Nov 5;268(31):23601–23610. [PubMed] [Google Scholar]
  27. Ross C. A., Danoff S. K., Schell M. J., Snyder S. H., Ullrich A. Three additional inositol 1,4,5-trisphosphate receptors: molecular cloning and differential localization in brain and peripheral tissues. Proc Natl Acad Sci U S A. 1992 May 15;89(10):4265–4269. doi: 10.1073/pnas.89.10.4265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Safrany S. T., Wilcox R. A., Liu C., Dubreuil D., Potter B. V., Nahorski S. R. Identification of partial agonists with low intrinsic activity at the inositol-1,4,5-trisphosphate receptor. Mol Pharmacol. 1993 Apr;43(4):499–503. [PubMed] [Google Scholar]
  29. Satoh T., Ross C. A., Villa A., Supattapone S., Pozzan T., Snyder S. H., Meldolesi J. The inositol 1,4,5,-trisphosphate receptor in cerebellar Purkinje cells: quantitative immunogold labeling reveals concentration in an ER subcompartment. J Cell Biol. 1990 Aug;111(2):615–624. doi: 10.1083/jcb.111.2.615. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Stehno-Bittel L., Lückhoff A., Clapham D. E. Calcium release from the nucleus by InsP3 receptor channels. Neuron. 1995 Jan;14(1):163–167. doi: 10.1016/0896-6273(95)90250-3. [DOI] [PubMed] [Google Scholar]
  31. Sugiyama T., Furuya A., Monkawa T., Yamamoto-Hino M., Satoh S., Ohmori K., Miyawaki A., Hanai N., Mikoshiba K., Hasegawa M. Monoclonal antibodies distinctively recognizing the subtypes of inositol 1,4,5-trisphosphate receptor: application to the studies on inflammatory cells. FEBS Lett. 1994 Nov 7;354(2):149–154. doi: 10.1016/0014-5793(94)01099-4. [DOI] [PubMed] [Google Scholar]
  32. Takei K., Mignery G. A., Mugnaini E., Südhof T. C., De Camilli P. Inositol 1,4,5-trisphosphate receptor causes formation of ER cisternal stacks in transfected fibroblasts and in cerebellar Purkinje cells. Neuron. 1994 Feb;12(2):327–342. doi: 10.1016/0896-6273(94)90275-5. [DOI] [PubMed] [Google Scholar]
  33. Taleb O., Betz H. Expression of the human glycine receptor alpha 1 subunit in Xenopus oocytes: apparent affinities of agonists increase at high receptor density. EMBO J. 1994 Mar 15;13(6):1318–1324. doi: 10.1002/j.1460-2075.1994.tb06384.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Taylor C. W., Richardson A. Structure and function of inositol trisphosphate receptors. Pharmacol Ther. 1991;51(1):97–137. doi: 10.1016/0163-7258(91)90043-l. [DOI] [PubMed] [Google Scholar]
  35. Wilcox R. A., Challiss R. A., Baudin G., Vasella A., Potter B. V., Nahorski S. R. Stereoselectivity of Ins(1,3,4,5)P4 recognition sites: implications for the mechanism of the Ins(1,3,4,5)P4-induced Ca2+ mobilization. Biochem J. 1993 Aug 15;294(Pt 1):191–194. doi: 10.1042/bj2940191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Wilcox R. A., Challiss R. A., Liu C., Potter B. V., Nahorski S. R. Inositol-1,3,4,5-tetrakisphosphate induces calcium mobilization via the inositol-1,4,5-trisphosphate receptor in SH-SY5Y neuroblastoma cells. Mol Pharmacol. 1993 Oct;44(4):810–817. [PubMed] [Google Scholar]
  37. Wilcox R. A., Challiss R. A., Traynor J. R., Fauq A. H., Ognayanov V. I., Kozikowski A. P., Nahorski S. R. Molecular recognition at the myo-inositol 1,4,5-trisphosphate receptor. 3-position substituted myo-inositol 1,4,5-trisphosphate analogues reveal the binding and Ca2+ release requirements for high affinity interaction with the myo-inositol 1,4,5-trisphosphate receptor. J Biol Chem. 1994 Oct 28;269(43):26815–26821. [PubMed] [Google Scholar]
  38. Wilcox R. A., Erneux C., Primrose W. U., Gigg R., Nahorski S. R. 2-Hydroxyethyl-alpha-D-glucopyranoside-2,3',4'-trisphosphate, a novel, metabolically resistant, adenophostin A and myo-inositol-1,4,5-trisphosphate analogue, potently interacts with the myo-inositol-1,4,5-trisphosphate receptor. Mol Pharmacol. 1995 Jun;47(6):1204–1211. [PubMed] [Google Scholar]
  39. Wilcox R. A., Whitham E. M., Liu C., Potter B. V., Nahorski S. R. Myo-inositol 1,3,4,5-tetrakisphosphate can independently mobilise intracellular calcium, via the inositol 1,4,5-trisphosphate receptor: studies with myo-inositol 1,4,5-trisphosphate-3-phosphorothioate and myo-inositol hexakisphosphate. FEBS Lett. 1993 Dec 27;336(2):267–271. doi: 10.1016/0014-5793(93)80817-e. [DOI] [PubMed] [Google Scholar]
  40. Wojcikiewicz R. J., Furuichi T., Nakade S., Mikoshiba K., Nahorski S. R. Muscarinic receptor activation down-regulates the type I inositol 1,4,5-trisphosphate receptor by accelerating its degradation. J Biol Chem. 1994 Mar 18;269(11):7963–7969. [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES